New frontiers in liver resection for hepatocellular carcinoma
2020 · JHEP Reports · 109 citations
https://doi.org/10.1016/j.jhepr.2020.100134
M
Mathilde Wagner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
145
Papers
3.2K
Citations
31
h-index
69
i10-index
Mathilde Wagner is an academic researcher from Sorbonne Université. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation. The author has an h-index of 31, co-authored 124 publications.
ORCID: 0000-0003-1172-4592Papers by this author
worksTreatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol
2020 · BMC Cancer · 18 citations
https://doi.org/10.1186/s12885-020-6571-7
RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study
2019 · Cancer Imaging · 13 citations
https://doi.org/10.1186/s40644-019-0271-z
Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survival
2024 · Clinics and Research in Hepatology and Gastroenterology · 9 citations
https://doi.org/10.1016/j.clinre.2024.102282
[18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study
2025 · The Lancet. Gastroenterology & hepatology · 4 citations
https://doi.org/10.1016/s2468-1253(25)00011-1
OS-077 Added value of a combination of positron emission tomography with 18F-FDG and 18 F-Fluorocholine for staging optimization and treatment modification in patients with hepatocellular carcinoma: the prospective multicentric PET HCC01 study
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)00518-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat